Target Bone remodellingClass Fluoride ionOther names NaF
Structure from the cited PubChem record (unlabelled ligand, or the labelled form when PubChem only describes that one). Conformer: RDKit (computed conformer, indicative). Rotate with the mouse or a finger.
| Form | Use | Molar mass (labelled form) | Ongoing trials | Most advanced phase | Approval |
|---|---|---|---|---|---|
| Na[¹⁸F]F Syntheses and QC ↗ | Imaging | 40.99 | 5 | Phase 2 | [18F]NaF (CISNAF, NaF MetaTrace…) US EU FR |
Atlas trials whose studied drug or title names this vector, with this radionuclide.
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| [18F]DCFPyL (piflufolastat)NCT03173924 · Prostate – other | Phase 2 | Active, not recruiting | National Cancer Institute (NCI) | 1 |
| [18F]NaFNCT07284563 · Bacterial infections | Phase 2 | Recruiting | Akiva Mintz | 1 |
| [18F]NaF2024-514759-13-01 · Inflammatory diseases | Phase 2 | Recruiting | Stichting Amsterdam UMC | 1 |
| [18F]FDGNCT06914999 · Atherosclerosis and vessels | Phase 1 | Recruiting | Emory University | 1 |
| SPECTRE · [18F]NaFNCT06013722 · Ischemic heart disease | No phase | Active, not recruiting | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 1 |
708 publications in PubMed for the query below; the most recent:
"sodium fluoride"[tiab] AND (PET[tiab] OR "18F"[tiab])
Sources: PubChem and PubMed (NCBI), ClinicalTrials.gov and CTIS registries, approvals recorded by the atlas. PubChem data as of 28 October 2026.
Sodium fluoride. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 27 October 2026. https://theranosticatlas.com/molecule/fluoride/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.